Wegovy Weight Loss
A New Drug for Weight Loss
Wegovy (semaglutide) is a new drug for weight loss that has been approved by the FDA. It is a once-weekly injectable medication that helps people lose weight and keep it off.
Wegovy is a GLP-1 receptor agonist, which means that it works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone that helps to regulate blood sugar levels and appetite.
When Wegovy is injected, it binds to GLP-1 receptors in the brain and gut. This causes a number of effects, including:
- Increased insulin secretion
- Decreased glucagon secretion
- Delayed gastric emptying
- Reduced appetite
These effects lead to weight loss by:
- Improving blood sugar control
- Reducing hunger and cravings
- Making people feel fuller after eating
Efficacy of Wegovy
Wegovy has been shown to be effective in clinical trials. In one study, people who took Wegovy lost an average of 12% of their body weight over a period of 68 weeks.
In another study, people who took Wegovy lost an average of 15% of their body weight over a period of 104 weeks.
Wegovy is generally well-tolerated. The most common side effects include nausea, vomiting, diarrhea, and constipation.
Cost of Wegovy
Wegovy is a prescription drug, and the cost can vary depending on your insurance coverage. The average cost of Wegovy is between $1,300 and $1,500 per month.
Comments